(VIANEWS) – Pfizer (PFE), Innospec (IOSP), Boston Omaha Corporation (BOMN) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Pfizer (PFE)

62.5% sales growth and 14.03% return on equity

Pfizer Inc. develops, manufactures, and sells healthcare products worldwide.

Pfizer’s sales growth this year is expected to be 74.9% and a negative 15% for next year.

Year-on-year quarterly revenue growth grew by 44.6%, now sitting on 46.41B for the twelve trailing months.

Volume

Today’s last reported volume for Pfizer is 17807100 which is 32.21% below its average volume of 26268300.

Pfizer’s sales growth for the next quarter is 62.5%. The company’s growth estimates for the current quarter and the next is 25.6% and 44.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.03%.

Volatility

Pfizer’s last day, last week, and last month’s current volatility was 0.25%, 0.59%, and 0.87%, respectively.

Pfizer’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.00% (day), 1.21% (last week), and 1.37% (last month), respectively.

Pfizer’s Stock Yearly Top and Bottom Value

Pfizer’s stock is valued at $39.61 at 20:22 EST, under its 52-week high of $43.08 and way higher than its 52-week low of $31.77.

Pfizer’s Moving Average

Pfizer’s value is higher than its 50-day moving average of $39.33 and higher than its 200-day moving average of $37.28.

Previous days news about Pfizer(PFE)

According to Bloomberg Quint on Tuesday, 6 July, "U.S. drugmakers Moderna Inc. and Pfizer Inc. are poised to benefit the most, along with China’s Sinovac Biotech Ltd. "

According to Bloomberg Quint on Tuesday, 6 July, "The shipment, which will be distributed by the vaccine sharing initiative Covax, consist of 5 million single-dose Johnson & Johnson vaccines and 10 million Pfizer Inc. shots, of which recipients need two, the organizations said in a July 5 communication to member states seen by Bloomberg. "

Israel says Pfizer vaccine is 64% effective against delta-variant infections. According to MarketWatch on Tuesday, 6 July, "Israel’s health ministry said Monday the effectiveness of the COVID-19 shot developed by BioNTech SE and Pfizer Inc. is now thought to be 64% at preventing symptomatic infections in that country. "

According to Business Insider on Tuesday, 6 July, "We have established partnerships with some of the world’s leading pharmaceutical companies and multiple emerging technology companies, including AbbVie, AstraZeneca, Biohaven, Genentech (Roche), Novartis, Pfizer and Takeda. "

According to MarketWatch on Tuesday, 6 July, "The percentage of U.S. adults who have received at least one vaccine dose stands at 67.1%, according to the latest data from a and Pfizer Inc. is traded mostly lower on Tuesday, taking a breather after rising to records before the holiday weekend."

2. Innospec (IOSP)

22.6% sales growth and 3.08% return on equity

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals worldwide.

Innospec’s sales growth this year is expected to be 14.6% and 7.4% for next year.

Year-on-year quarterly revenue growth declined by 20.5%, now sitting on 1.19B for the twelve trailing months.

Volume

Today’s last reported volume for Innospec is 92439 which is 9.49% below its average volume of 102128.

Innospec’s sales growth is a negative 0% for the ongoing quarter and 22.6% for the next. The company’s growth estimates for the present quarter and the next is 594.4% and 39.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.08%.

Volatility

Innospec’s last day, last week, and last month’s current volatility was 0.57%, 0.91%, and 1.25%, respectively.

Innospec’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.11% (day), 2.79% (last week), and 2.68% (last month), respectively.

Innospec’s Stock Yearly Top and Bottom Value

Innospec’s stock is valued at $90.49 at 20:22 EST, way under its 52-week high of $107.73 and way above its 52-week low of $61.48.

Innospec’s Moving Average

Innospec’s value is below its 50-day moving average of $97.37 and under its 200-day moving average of $98.20.

3. Boston Omaha Corporation (BOMN)

17.9% sales growth and 23.57% return on equity

Boston Omaha Corporation, together with its subsidiaries, engages in the outdoor billboard advertising business in the southeast United States.

Boston Omaha Corporation’s sales growth this year is expected to be 21.5% and 6.7% for next year.

Year-on-year quarterly revenue growth grew by 15.7%, now sitting on 47.54M for the twelve trailing months.

Volume

Today’s last reported volume for Boston Omaha Corporation is 115415 which is 21.87% below its average volume of 147716.

Boston Omaha Corporation’s sales growth is a negative 0% for the ongoing quarter and 17.9% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 0% and negative -114.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.57%.

Volatility

Boston Omaha Corporation’s last day, last week, and last month’s current volatility was 2.48%, 1.67%, and 1.82%, respectively.

Boston Omaha Corporation’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.18% (day), 3.89% (last week), and 4.40% (last month), respectively.

Boston Omaha Corporation’s Stock Yearly Top and Bottom Value

Boston Omaha Corporation’s stock is valued at $30.29 at 20:22 EST, way under its 52-week high of $49.92 and way above its 52-week low of $14.80.

Boston Omaha Corporation’s Moving Average

Boston Omaha Corporation’s worth is below its 50-day moving average of $31.25 and under its 200-day moving average of $32.17.

4. MagnaChip Semiconductor Corporation (MX)

17.1% sales growth and 40.41% return on equity

MagnaChip Semiconductor Corporation, together with its subsidiaries, designs, manufactures, and sells analog and mixed-signal semiconductor platform solutions for communications, Internet of Things, consumer, industrial, and automotive applications.

MagnaChip Semiconductor Corporation’s sales growth this year is expected to be 5.7% and 8.4% for next year.

Year-on-year quarterly revenue growth grew by 2.1%, now sitting on 509.6M for the twelve trailing months.

Volume

Today’s last reported volume for MagnaChip Semiconductor Corporation is 138596 which is 83.8% below its average volume of 855379.

MagnaChip Semiconductor Corporation’s sales growth is a negative 0% for the current quarter and 17.1% for the next. The company’s growth estimates for the ongoing quarter and the next is 53.8% and 92.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 40.41%.

Volatility

MagnaChip Semiconductor Corporation’s last day, last week, and last month’s current volatility was 3.85%, 2.13%, and 1.40%, respectively.

MagnaChip Semiconductor Corporation’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.74% (day), 3.41% (last week), and 3.36% (last month), respectively.

MagnaChip Semiconductor Corporation’s Stock Yearly Top and Bottom Value

MagnaChip Semiconductor Corporation’s stock is valued at $23.74 at 20:22 EST, way under its 52-week high of $26.98 and way above its 52-week low of $9.93.

MagnaChip Semiconductor Corporation’s Moving Average

MagnaChip Semiconductor Corporation’s worth is below its 50-day moving average of $23.95 and higher than its 200-day moving average of $21.65.

5. Solar Capital Ltd. (SLRC)

15.3% sales growth and 13.47% return on equity

Solar Capital Ltd.

Solar Capital Ltd.’s sales growth this year is expected to be 17.6% and 7.3% for next year.

Year-on-year quarterly revenue growth grew by 9.1%, now sitting on 124.73M for the twelve trailing months.

Volume

Today’s last reported volume for Solar Capital Ltd. is 91833 which is 41.67% below its average volume of 157439.

Solar Capital Ltd.’s sales growth for the next quarter is 15.3%. The company’s growth estimates for the present quarter and the next is 8.8% and 14.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.47%.

Volatility

Solar Capital Ltd.’s last day, last week, and last month’s current volatility was 0.05%, 0.42%, and 0.79%, respectively.

Solar Capital Ltd.’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.87% (day), 1.40% (last week), and 1.54% (last month), respectively.

Solar Capital Ltd.’s Stock Yearly Top and Bottom Value

Solar Capital Ltd.’s stock is valued at $19.31 at 20:22 EST, under its 52-week high of $19.69 and way higher than its 52-week low of $15.08.

Solar Capital Ltd.’s Moving Average

Solar Capital Ltd.’s worth is above its 50-day moving average of $18.95 and higher than its 200-day moving average of $18.47.

6. StoneCastle Financial Corp (BANX)

7.2% sales growth and 20.62% return on equity

StoneCastle Financial Corp. is a closed ended balanced mutual fund launched and managed by StoneCastle Asset Management LLC.

StoneCastle Financial Corp’s sales growth this year is expected to be 7.4% and 9.7% for next year.

Year-on-year quarterly revenue growth grew by 11.9%, now sitting on 17.09M for the twelve trailing months.

Volume

Today’s last reported volume for StoneCastle Financial Corp is 5627 which is 71.22% below its average volume of 19550.

StoneCastle Financial Corp’s sales growth is a negative 0% for the current quarter and 7.2% for the next. The company’s growth estimates for the present quarter and the next is 2.4% and 4.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.62%.

Volatility

StoneCastle Financial Corp’s last day, last week, and last month’s current volatility was 0.41%, 0.70%, and 0.91%, respectively.

StoneCastle Financial Corp’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.48% (day), 1.79% (last week), and 1.82% (last month), respectively.

StoneCastle Financial Corp’s Stock Yearly Top and Bottom Value

StoneCastle Financial Corp’s stock is valued at $21.89 at 20:22 EST, below its 52-week high of $22.67 and way above its 52-week low of $16.04.

StoneCastle Financial Corp’s Moving Average

StoneCastle Financial Corp’s worth is higher than its 50-day moving average of $21.85 and higher than its 200-day moving average of $20.51.

7. ManTech International Corporation (MANT)

7.2% sales growth and 7.98% return on equity

ManTech International Corporation provides technology solutions and services for U.S. defense, intelligence community, and federal civilian agencies worldwide.

ManTech International Corporation’s sales growth this year is expected to be 6% and 5% for next year.

Year-on-year quarterly revenue growth grew by 3.7%, now sitting on 2.54B for the twelve trailing months.

Volume

Today’s last reported volume for ManTech International Corporation is 81769 which is 47.38% below its average volume of 155404.

ManTech International Corporation’s sales growth is a negative 0% for the ongoing quarter and 7.2% for the next. The company’s growth estimates for the present quarter and the next is 3.6% and 6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.98%.

Volatility

ManTech International Corporation’s last day, last week, and last month’s current volatility was 0.05%, 0.33%, and 0.85%, respectively.

ManTech International Corporation’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.63% (day), 1.97% (last week), and 2.81% (last month), respectively.

ManTech International Corporation’s Stock Yearly Top and Bottom Value

ManTech International Corporation’s stock is valued at $86.95 at 20:22 EST, way under its 52-week high of $101.35 and way above its 52-week low of $61.91.

ManTech International Corporation’s Moving Average

ManTech International Corporation’s value is below its 50-day moving average of $87.56 and higher than its 200-day moving average of $86.62.

LEAVE A REPLY

Please enter your comment!
Please enter your name here